WALTHAM, Mass. & MONTREAL–(BUSINESS WIRE)–Ventus Therapeutics, Inc., a biopharmaceutical company utilizing structural biology and a proprietary computational chemistry platform to identify and develop differentiated small molecule therapeutics across a broad range of diseases, announced today that its President and Chief Executive Officer, Marcelo Bigal, M.D., Ph.D., will present at the 2023 Bloom Burton & Co. … [Read more…]

TCR and CAR libraries enable comprehensive screening of combinations of custom gene parts including domains from TCRs and CARs Information about the offering available at AACR Annual Meeting 2023 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aviceda Therapeutics, a private clinical-stage biotech company focused on developing next generation immuno-modulators by harnessing the power of glycobiology to modulate the innate immune system and alleviate chronic, non-resolving inflammation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the IND for AVD-104, enabling the company to proceed with initiating … [Read more…]

Top-Line Results Expected in the First Half of 2023 LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced completion of enrollment in the Phase 3 INVIGORATE-2 clinical trial of topical ocular reproxalap, a first-in-class investigational new drug candidate, for the treatment of allergic conjunctivitis. “Today, millions of allergic conjunctivitis patients rely on therapies that … [Read more…]

SARASOTA, Fla.–(BUSINESS WIRE)–#Eyecare–US Eye, a patient-centric network of premium eye care practices, is proud to announce that sixteen US Eye physicians have been named to the 2023 list of Top Doctors published by Castle Connolly Medical, Ltd. Castle Connolly Top Doctors are peer-nominated, and thoroughly vetted by a physician-led research team. The Castle Connolly research … [Read more…]

DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for U.S. Patent Application No. 16/606,856, titled “Engineered meganucleases specific for recognition … [Read more…]

New Technology Provides Cutting Edge Visualization, Ergonomic Positioning and Efficient Workflow VAUGHAN, Ontario & HEIDELBERG, Germany–(BUSINESS WIRE)–Bausch + Lomb, a leading global eye health company dedicated to helping people see better to live better, and Heidelberg Engineering, today announced the introduction of the SeeLuma™ Fully Digital Surgical Visualization Platform, which provides ophthalmic surgeons with a … [Read more…]

IRVING, Texas–(BUSINESS WIRE)–#Afib—Vizient, Inc. released its latest Medical Device Tech Watch, examining care models for cardiac arrhythmia, methods for improving colorectal cancer screening rates and how optimizing surgical tray standardization can reduce costs and improve operational efficiencies. Access Medical Device Tech Watch. “This edition of Tech Watch explores a variety of topics, including emerging artificial … [Read more…]

CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC announced it acted as administrative agent and joint lead arranger on the funding of a senior credit facility to support the acquisition of Medusind by private equity sponsor Alpine Investors. Founded in 2002 and based in Miami, Florida, Medusind is a leading provider of technology solutions and revenue cycle management services … [Read more…]

Presentations demonstrate therapeutic potential of Turnstone’s selected tumor-infiltrating lymphocyte therapy in a broad range of solid tumors and support ongoing clinical efforts for its lead program, TIDAL-01 SAN DIEGO–(BUSINESS WIRE)–#AACR2023–Turnstone Biologics Corp, a clinical-stage biotechnology company developing next-generation immunotherapies to treat solid tumors, today announced that two abstracts have been accepted for poster presentations at … [Read more…]